Arzneiwerk VIDA Past Earnings Performance

Past criteria checks 0/6

Arzneiwerk VIDA's earnings have been declining at an average annual rate of -69%, while the Healthcare industry saw earnings declining at 0.8% annually. Revenues have been growing at an average rate of 53.7% per year.

Key information

-69.0%

Earnings growth rate

-64.0%

EPS growth rate

Healthcare Industry Growth15.7%
Revenue growth rate53.7%
Return on equityn/a
Net Margin-4.3%
Next Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Arzneiwerk VIDA makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:TLIK Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 2461-320
31 Dec 2359-320
30 Sep 23-11-320
31 Mar 2369-1730
31 Dec 2273-1730
30 Sep 2258-120
30 Jun 2241020
31 Mar 2221020
31 Dec 213010
30 Sep 212130
30 Jun 213120
31 Mar 213120
31 Dec 203120
30 Sep 203200
30 Jun 203400
31 Mar 203400
31 Dec 194400
30 Sep 1975-2-1
30 Jun 1972-1-1
31 Mar 1962-1-1
31 Dec 185100
30 Sep 184021
30 Jun 184-132
31 Mar 186033
31 Dec 177133
30 Sep 176332
30 Jun 177432
31 Mar 177332
31 Dec 167332
30 Sep 167132
30 Jun 167132
31 Mar 167033
31 Dec 156-142
30 Sep 156-343
30 Jun 157-342
31 Mar 1510-253
31 Dec 148-142
30 Sep 149052
30 Jun 149052
31 Mar 1411063
31 Dec 1311163
30 Sep 1311063

Quality Earnings: TLIK is currently unprofitable.

Growing Profit Margin: TLIK is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: TLIK is unprofitable, and losses have increased over the past 5 years at a rate of 69% per year.

Accelerating Growth: Unable to compare TLIK's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: TLIK is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (13.2%).


Return on Equity

High ROE: TLIK's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Discover strong past performing companies